Evidence map›Paper›PMID 37836654›Full record

ReviewMolecules (Basel, Switzerland)2023

Protective Application of Chinese Herbal Compounds and Formulae in Intestinal Inflammation in Humans and Animals.

Yang Yang, Gang Xiao, Pi Cheng, Jianguo Zeng, Yisong Liu

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Supramolecular prodrug inspiried by theJournal of pharmaceutical analysis · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Frontiers in veterinary science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yang YangCollege of Veterinary Medicine, Hunan Agricultural University, Changsha 410125, China.
Gang XiaoCollege of Veterinary Medicine, Hunan Agricultural University, Changsha 410125, China.
Pi ChengCollege of Veterinary Medicine, Hunan Agricultural University, Changsha 410125, China.
Jianguo ZengCollege of Veterinary Medicine, Hunan Agricultural University, Changsha 410125, China.
Yisong LiuCollege of Veterinary Medicine, Hunan Agricultural University, Changsha 410125, China.
Hunan Agricultural University · CNHunan University of Traditional Chinese Medicine · CN

Funding

the National Key R&D Program of China 2017YFD0501500the Natural Science Foundation of Changsha kq2202232the Research Foundation of the Education Bureau of Hunan Province 22A0146
6 · The paper itself

Abstract

Intestinal inflammation is a chronic gastrointestinal disorder with uncertain pathophysiology and causation that has significantly impacted both the physical and mental health of both people and animals. An increasing body of research has demonstrated the critical role of cellular signaling pathways in initiating and managing intestinal inflammation. This review focuses on the interactions of three cellular signaling pathways (TLR4/NF-κB, PI3K-AKT, MAPKs) with immunity and gut microbiota to explain the possible pathogenesis of intestinal inflammation. Traditional medicinal drugs frequently have drawbacks and negative side effects. This paper also summarizes the pharmacological mechanism and application of Chinese herbal compounds (Berberine, Sanguinarine, Astragalus polysaccharide, Curcumin, and Cannabinoids) and formulae (Wumei Wan, Gegen-Qinlian decoction, Banxia xiexin decoction) against intestinal inflammation. We show that the herbal compounds and formulae may influence the interactions among cell signaling pathways, immune function, and gut microbiota in humans and animals, exerting their immunomodulatory capacity and anti-inflammatory and antimicrobial effects. This demonstrates their strong potential to improve gut inflammation. We aim to promote herbal medicine and apply it to multispecies animals to achieve better health.

Indexed as

Drugs, Chinese HerbalPhosphatidylinositol 3-KinasesAnimalsAnti-Inflammatory AgentsHumansInflammationMedicine, Chinese TraditionalNF-kappa BAnti-Inflammatory AgentsDrugs, Chinese HerbalNF-kappa BPhosphatidylinositol 3-Kinasescellular signaling pathwayChinese herbal compoundsChinese herbal formulaegut healthintestinal inflammation

Identifiers

PMID37836654
PMCPMC10574200
OpenAlexW4387101708

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.